Angel Investor

Updated:

Founder’s Edge

Founder’s Edge operates as a partnership of three practitioner-angels.

Founder’s Edge

Founder’s Edge operates as a partnership of three practitioner-angels. The firm’s website lists Henry Nilert — co-founder of iobox and Credit24 — alongside Ali Omar, who built Med Group (Onni Terveys) from zero to €100m revenue before its 2018 sale, and Pekka Ylitalo, an MD PhD who runs a family office portfolio and sits on portfolio-company boards. They invest from their own balance sheets without external LP capital, describing the vehicle as “early stage investments from founders to founders.” The firm targets pre-seed rounds, typically writing €100k–250k tickets and often taking the lead in larger rounds where they co-invest alongside Nordic seed funds and other angels. While the stated core is B2B SaaS — spanning fintech, healthtech, and enterprise productivity — the portfolio also reaches into hardware, media, and logistics. Confirmed positions include open-banking platform Nordigen, clinical-trial software provider Claned, smart-water analytics company Smartvatten, and AI-powered social listening tool Exolyt. Geographic deployment is concentrated in Finland but extends to the Baltics and other Nordic countries. The three partners bring overlapping clinical and entrepreneurial backgrounds. Ali Omar and Pekka Ylitalo are both medical doctors, giving the group unusual diligence depth on regulated healthtech and pharma assets such as Aurealis Therapeutics and Buddy Healthcare. Nilert contributes fintech and marketplace operating experience from iobox and Credit24, which aligns with portfolio companies like Nordigen and GoalProfit. The firm does not disclose total deployment figures or headcount beyond the three named partners listed on its site. Founder’s Edge is structurally a pooled angel syndicate rather than a fund — there is no closed-end vehicle, no disclosed limited partners, and no institutional fundraising cycle. That architecture lets the group hold concentrated positions with patient, balance-sheet capital. The absence of a fund structure also means no external reporting obligations; the firm’s public footprint is limited to its own website and the startup announcements of its portfolio companies.

General information

Firm type

Angel Group

Year founded

AUM

Undisclosed

Location

Region

Europe

Country

Finland

City

Helsinki

Corporate office

Helsinki, Finland

Principals

Henry Nilert

Partner

Ali Omar

Partner

Pekka Ylitalo

Partner

Sector focus

Enterprise SoftwareFinTechDigital HealthMedia & EntertainmentMobility & TransportationHealthcare ServicesPropTech

Frequently asked questions

Who runs investment decisions at Founder’s Edge?

The three partners — Henry Nilert, Ali Omar, and Pekka Ylitalo — make investment decisions together. Each has an entrepreneurial exit in his background: Nilert co-founded iobox and Credit24, Omar built and sold Med Group, and Ylitalo runs a family office while holding board seats. The firm’s website presents them as equal partners without a separate investment committee.

Is Founder’s Edge a fund or an angel syndicate?

It operates as an angel syndicate, not a closed-end venture fund. The partners invest from their own capital and do not disclose any external limited partners. There is no indication of a management fee or carried interest structure on the firm’s public materials.

What check sizes and stages does Founder’s Edge target?

Initial tickets range from €100k to €250k in pre-seed rounds. The firm states it often takes the lead in larger rounds and co-invests alongside seed funds and other angel investors. Later-stage or growth equity is not listed as a focus.

Does Founder’s Edge invest outside Finland?

Yes. The firm’s primary geographic focus is Finland, but it explicitly includes the Baltic countries and other Nordic nations in its investment scope. Portfolio companies such as Nordigen (Latvia) and Smartvatten (Finland and the Netherlands) reflect that broader Nordic-Baltic footprint.

Which sectors does Founder’s Edge explicitly favor?

B2B SaaS is the stated core, with particular density in fintech and healthtech. The partners’ clinical backgrounds create a natural emphasis on regulated digital health and pharma — portfolio examples include Aurealis Therapeutics, Buddy Healthcare, and Claned. Enterprise productivity tools, marketplaces, and select hardware or media assets also appear in the portfolio.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Helsinki Angel Group profiles